Inventor

LIENAU PHILIP

DE78 patents

⚠️ This page may combine multiple inventors who share the name “LIENAU PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIENAU PHILIP

Bayer Pharma AG

2-(morpholin-4-yl)-1,7-naphthyridines

5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

2-(morpholin-4-yl)-1,7-naphthyridines

Thienopyrimidines

Amino-substituted imidazopyridazines

Macrocyclic compounds

Macrocyclic sulfondiimine compounds

Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors

4H-pyrrolo[3,2-C]pyridin-4-one derivatives

Substituted triazolopyridines

Modified macrocyclic compounds

Compounds, compositions and methods for cancer patient stratification and cancer treatment

Compounds, compositions and methods for cancer patient stratification and cancer treatment

Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors

Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group

4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group

BAYER AG

Macrocyclic indole derivatives

Dihydrooxadiazinones

Dihydrooxadiazinones

Macrocyclic indole derivatives

Dihydrooxadiazinones

PTEFB inhibiting macrocyclic compounds

PTEFb inhibiting macrocyclic compounds

PTEFb inhibiting macrocyclic compounds

1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases

Lücking Ulrich

Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines

Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine

Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine

Disubstituted 5-fluoro-pyrimidines

BAYER IP GMBH

Substituted imidazopyridazines

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases

EIS KNUT

Substituted aminoimidazopyridazines

Heterocyclyl aminoimidazopyridazines

Amino-substituted imidazopyridazines

KLAR ULRICH

Substituted imidazopyridazines

Substituted imidazopyrazines

KOPPITZ MARCUS

Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors

6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors

BADER BENJAMIN

Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors

BROAD INST INC

Compounds, compositions and methods for cancer treatment

LIU NINGSHU

(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment